Researchers are developing ‘artificial brains’ that can test early versions of dementia drugs and hope to begin clinical trials begin within five years.
lars-ittner
Researchers are developing ‘artificial brains’ that can test early versions of dementia drugs and hope to begin clinical trials begin within five years.
You don’t have any saved content.